Andere Sprachen Applied DNA Sciences, Inc.

Aktien

A40ANB

US03815U4094

APDN

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 02.05.2024			% 5 Tage	% 1. Jan.
4,09 ^USD	+1,49 %		-18,20 %	-66,85 %

25.04.	Applied DNA Sciences, Inc. erhält Auftrag von HDT Bio für schnelles Impfstoffentwicklungsprogramm	CI
14.03.	Applied DNA Sciences, Inc. präsentiert Linea DNA und Linea IVT Plattformen auf dem 24. jährlichen Weltimpfstoffkongress	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program	26.04.
Applied DNA Sciences, Inc. Receives Contract by HDT Bio for Rapid Vaccine Development Program	25.04.
Certain Warrants of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	03.04.
Certain Options of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	03.04.
Certain Common Stock of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	03.04.
Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress	15.03.
Applied DNA Sciences, Inc. to Showcase Linea DNA and Linea IVT Platforms At 24Th Annual World Vaccine Congress	14.03.
Applied DNA Sciences Files Prospectus for Potential Secondary Stock Offerings	12.03.
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot	08.02.
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q1 Revenue $891,164	08.02.
Applied DNA Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	08.02.
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	01.02.
Applied DNA Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology's mRNA Manufacturing Workflow	15.12.
Applied DNA Sciences, Inc. Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology?s mRNA Manufacturing Workflow	14.12.
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot	07.12.
Earnings Flash (APDN) APPLIED DNA SCIENCES Posts Q4 Revenue $779,736, vs. Street Est of $1.7M	07.12.
Applied DNA Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	07.12.
Applied DNA Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	07.12.
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023	06.12.
Applied DNA Sciences, Inc. Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application	28.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Applied DNA Sciences, Inc.

Aktien

A40ANB

US03815U4094

APDN

Andere Sprachen

Filter